Detalhe da pesquisa
1.
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer.
J Urol
; 206(1): 80-87, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683939
2.
Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer.
Cancer Res
; 82(8): 1518-1533, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131873
3.
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
JCI Insight
; 7(4)2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050902
4.
Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34568716
5.
Phosphorylation of the androgen receptor at Ser81 is co-sustained by CDK1 and CDK9 and leads to AR-mediated transactivation in prostate cancer.
Mol Oncol
; 15(7): 1901-1920, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33932081
6.
A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes.
Clin Cancer Res
; 27(17): 4836-4847, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168052
7.
EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer.
Nat Cancer
; 2(4): 444-456, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899001
8.
Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
J Clin Invest
; 130(6): 3287-3298, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32478682
9.
Primary adenocarcinoma of the bladder lacks mismatch repair deficiency and demonstrates PD-L1 expression in tumor-infiltrating immune cells, with implications in both diagnosis and therapeutics.
Hum Pathol
; 94: 58-63, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31666198
10.
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone.
J Clin Oncol
; 37(11): 923-931, 2019 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30811282
11.
Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition.
Oncotarget
; 9(47): 28532-28546, 2018 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29983878
12.
Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.
Cancer Lett
; 438: 97-104, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217568
13.
Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer.
Cancer Res
; 78(22): 6354-6362, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242112
14.
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations.
Cancer Res
; 78(16): 4716-4730, 2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29921690
15.
Expression of PD-L1 in Hormone-naïve and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide.
Clin Cancer Res
; 23(22): 6812-6822, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28893901